An approach to use of an adaptive procedure to clinical trials for molecularly heterogenous subject selection at interim
From MaRDI portal
Publication:5085585
DOI10.1080/03610926.2018.1543770OpenAlexW2902329286MaRDI QIDQ5085585
Publication date: 27 June 2022
Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610926.2018.1543770
Cites Work
- Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost
- Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design
- A sample size adjustment procedure for clinical trials based on conditional power
This page was built for publication: An approach to use of an adaptive procedure to clinical trials for molecularly heterogenous subject selection at interim
